(505) 254-7784 pchelp@pcsanm.org
  • About Us
    • Mission Statement
    • Our Board
    • Organization Description
    • Donate
  • Contact Us
0 Items
Prostate Cancer Support Association of New Mexico
  • Home
  • Start Here
    • Beginner’s Guide
    • Next Steps
  • Meetings
  • Resources
  • Education & Info
    • Helpful Prostate Cancer-Related Websites
    • NM Cancer Resources & Support
    • News You Can Use
    • For Medical Professionals
  • Annual Conference
  • Newsletters
  • Early Detection
    • Early Detection
    • Free PSA Test
Select Page

Personalizing Prostate Cancer Care With Genetic Testing, PARP Inhibitors

by admin_63069 | Jul 17, 2025 | Related Topics

Genetic testing, including germline and somatic, is crucial for high-risk and advanced prostate cancer, guiding treatment decisions and family counseling.

What Are the Best Practices for Prostate Cancer Screening?

by admin_63069 | Jul 10, 2025 | Related Topics

Former President Joe Biden recently announced that he had been diagnosed with an aggressive form of prostate cancer. The news sparked a larger conversation about what exactly the best practices are to screen for prostate cancer. Turns out, it’s more complicated than...

New Insight into Genetic Drivers of Prostate Cancer

by admin_63069 | Jun 19, 2025 | Related Topics

A recent multinational study has identified genetic clues explaining why some prostate cancers remain slow-growing while others become life-threatening.

Advanced Imaging and Targeted Therapy Help Men with Prostate Cancer Safely Defer Surgery and Radiation Therapy

by admin_63069 | Jun 5, 2025 | Related Topics

UCLA researchers looked at how using MRI, MRI-guided biopsies and focal therapy can help men with prostate cancer remain on active surveillance.

Decipher Prostate Test Now Available for Metastatic Prostate Cancer

by admin_63069 | May 28, 2025 | Related Topics

The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels.

Males Who Skip Prostate Screenings Could Face 45% Higher Risk of Death

by admin_63069 | May 14, 2025 | Related Topics

Men who avoided prostate cancer screening were significantly more likely to die from the disease, according to a large European trial.
« Older Entries
Next Entries »

What’s New

  • Reduced Screening May Have Led to Rise in Advanced Prostate Cancer Diagnoses
  • UChicago Medicine Emerges as a Global Leader in Focal Therapy Treatments
  • FDA grants fast track designation to HLD-0915 in mCRPC
  • FDA Accepts NDA for New Formulation of PSMA PET Injection in Prostate Cancer
  • Insurers’ Use of Artificial Intelligence (AI)

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org

  • Donate
  • Contact Us